Literature DB >> 33741907

Identification of disease treatment mechanisms through the multiscale interactome.

Camilo Ruiz1,2, Marinka Zitnik3, Jure Leskovec4,5.   

Abstract

Most diseases disrupt multiple proteins, and drugs treat such diseases by restoring the functions of the disrupted proteins. How drugs restore these functions, however, is often unknown as a drug's therapeutic effects are not limited to the proteins that the drug directly targets. Here, we develop the multiscale interactome, a powerful approach to explain disease treatment. We integrate disease-perturbed proteins, drug targets, and biological functions into a multiscale interactome network. We then develop a random walk-based method that captures how drug effects propagate through a hierarchy of biological functions and physical protein-protein interactions. On three key pharmacological tasks, the multiscale interactome predicts drug-disease treatment, identifies proteins and biological functions related to treatment, and predicts genes that alter a treatment's efficacy and adverse reactions. Our results indicate that physical interactions between proteins alone cannot explain treatment since many drugs treat diseases by affecting the biological functions disrupted by the disease rather than directly targeting disease proteins or their regulators. We provide a general framework for explaining treatment, even when drugs seem unrelated to the diseases they are recommended for.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33741907     DOI: 10.1038/s41467-021-21770-8

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  89 in total

Review 1.  Biological networks and analysis of experimental data in drug discovery.

Authors:  Yuri Nikolsky; Tatiana Nikolskaya; Andrej Bugrim
Journal:  Drug Discov Today       Date:  2005-05-01       Impact factor: 7.851

Review 2.  Network propagation: a universal amplifier of genetic associations.

Authors:  Lenore Cowen; Trey Ideker; Benjamin J Raphael; Roded Sharan
Journal:  Nat Rev Genet       Date:  2017-06-12       Impact factor: 53.242

Review 3.  Network biology concepts in complex disease comorbidities.

Authors:  Jessica Xin Hu; Cecilia Engel Thomas; Søren Brunak
Journal:  Nat Rev Genet       Date:  2016-08-08       Impact factor: 53.242

Review 4.  Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders.

Authors:  Neelroop N Parikshak; Michael J Gandal; Daniel H Geschwind
Journal:  Nat Rev Genet       Date:  2015-07-07       Impact factor: 53.242

5.  Pathway and network analysis of cancer genomes.

Authors:  Pau Creixell; Jüri Reimand; Syed Haider; Guanming Wu; Tatsuhiro Shibata; Miguel Vazquez; Ville Mustonen; Abel Gonzalez-Perez; John Pearson; Chris Sander; Benjamin J Raphael; Debora S Marks; B F Francis Ouellette; Alfonso Valencia; Gary D Bader; Paul C Boutros; Joshua M Stuart; Rune Linding; Nuria Lopez-Bigas; Lincoln D Stein
Journal:  Nat Methods       Date:  2015-07       Impact factor: 28.547

Review 6.  Network medicine: a network-based approach to human disease.

Authors:  Albert-László Barabási; Natali Gulbahce; Joseph Loscalzo
Journal:  Nat Rev Genet       Date:  2011-01       Impact factor: 53.242

7.  Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes.

Authors:  Mark D M Leiserson; Fabio Vandin; Hsin-Ta Wu; Jason R Dobson; Jonathan V Eldridge; Jacob L Thomas; Alexandra Papoutsaki; Younhun Kim; Beifang Niu; Michael McLellan; Michael S Lawrence; Abel Gonzalez-Perez; David Tamborero; Yuwei Cheng; Gregory A Ryslik; Nuria Lopez-Bigas; Gad Getz; Li Ding; Benjamin J Raphael
Journal:  Nat Genet       Date:  2014-12-15       Impact factor: 38.330

8.  The discovery of integrated gene networks for autism and related disorders.

Authors:  Fereydoun Hormozdiari; Osnat Penn; Elhanan Borenstein; Evan E Eichler
Journal:  Genome Res       Date:  2014-11-05       Impact factor: 9.043

9.  Architecture of the human interactome defines protein communities and disease networks.

Authors:  Edward L Huttlin; Raphael J Bruckner; Joao A Paulo; Joe R Cannon; Lily Ting; Kurt Baltier; Greg Colby; Fana Gebreab; Melanie P Gygi; Hannah Parzen; John Szpyt; Stanley Tam; Gabriela Zarraga; Laura Pontano-Vaites; Sharan Swarup; Anne E White; Devin K Schweppe; Ramin Rad; Brian K Erickson; Robert A Obar; K G Guruharsha; Kejie Li; Spyros Artavanis-Tsakonas; Steven P Gygi; J Wade Harper
Journal:  Nature       Date:  2017-05-17       Impact factor: 49.962

10.  Network-based approach to prediction and population-based validation of in silico drug repurposing.

Authors:  Feixiong Cheng; Rishi J Desai; Diane E Handy; Ruisheng Wang; Sebastian Schneeweiss; Albert-László Barabási; Joseph Loscalzo
Journal:  Nat Commun       Date:  2018-07-12       Impact factor: 14.919

View more
  13 in total

Review 1.  Recycled Translation: Repurposing Drugs for Stroke.

Authors:  Samantha E Spellicy; David C Hess
Journal:  Transl Stroke Res       Date:  2022-02-26       Impact factor: 6.829

2.  Metabolic network-based identification of plasma markers for non-small cell lung cancer.

Authors:  Linling Guo; Linrui Li; Zhiyun Xu; Fanchen Meng; Huimin Guo; Peijia Liu; Peifang Liu; Yuan Tian; Fengguo Xu; Zunjian Zhang; Shuai Zhang; Yin Huang
Journal:  Anal Bioanal Chem       Date:  2021-10-07       Impact factor: 4.142

3.  Drug repositioning by merging active subnetworks validated in cancer and COVID-19.

Authors:  Marta Lucchetta; Marco Pellegrini
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.379

4.  Network analysis reveals rare disease signatures across multiple levels of biological organization.

Authors:  Pisanu Buphamalai; Tomislav Kokotovic; Vanja Nagy; Jörg Menche
Journal:  Nat Commun       Date:  2021-11-09       Impact factor: 14.919

5.  Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease.

Authors:  Michael G Sugiyama; Haotian Cui; Dar'ya S Redka; Mehran Karimzadeh; Edurne Rujas; Hassaan Maan; Sikander Hayat; Kyle Cheung; Rahul Misra; Joseph B McPhee; Russell D Viirre; Andrew Haller; Roberto J Botelho; Raffi Karshafian; Sarah A Sabatinos; Gregory D Fairn; Seyed Ali Madani Tonekaboni; Andreas Windemuth; Jean-Philippe Julien; Vijay Shahani; Stephen S MacKinnon; Bo Wang; Costin N Antonescu
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

Review 6.  Application of nanomaterials in proteomics-driven precision medicine.

Authors:  Yong Zhang; Haonan Yang; Yanbao Yu; Ying Zhang
Journal:  Theranostics       Date:  2022-03-06       Impact factor: 11.600

Review 7.  From pharmacogenetics to pharmaco-omics: Milestones and future directions.

Authors:  Chiara Auwerx; Marie C Sadler; Alexandre Reymond; Zoltán Kutalik
Journal:  HGG Adv       Date:  2022-03-16

Review 8.  Artificial intelligence in cancer target identification and drug discovery.

Authors:  Yujie You; Xin Lai; Yi Pan; Huiru Zheng; Julio Vera; Suran Liu; Senyi Deng; Le Zhang
Journal:  Signal Transduct Target Ther       Date:  2022-05-10

9.  Schizophrenia Plays a Negative Role in the Pathological Development of Myocardial Infarction at Multiple Biological Levels.

Authors:  Xiaorong Yang; Yao Chen; Huiyao Wang; Xia Fu; Kamil Can Kural; Hongbao Cao; Ying Li
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

10.  Development of a Multi-Target Strategy for the Treatment of Vitiligo via Machine Learning and Network Analysis Methods.

Authors:  Jiye Wang; Lin Luo; Qiong Ding; Zengrui Wu; Yayuan Peng; Jie Li; Xiaoqin Wang; Weihua Li; Guixia Liu; Bo Zhang; Yun Tang
Journal:  Front Pharmacol       Date:  2021-09-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.